Stratos Wealth Partners’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $485K | Sell |
14,389
-1,157
| -7% | -$39K | 0.01% | 943 |
|
|
2025
Q1 | $494K | Buy |
15,546
+150
| +1% | +$4.77K | 0.01% | 889 |
|
|
2024
Q4 | $598K | Sell |
15,396
-2,520
| -14% | -$97.9K | 0.01% | 862 |
|
|
2024
Q3 | $806K | Sell |
17,916
-2,294
| -11% | -$103K | 0.01% | 761 |
|
|
2024
Q2 | $844K | Buy |
20,210
+1,857
| +10% | +$77.5K | 0.01% | 710 |
|
|
2024
Q1 | $835K | Buy |
18,353
+7,099
| +63% | +$323K | 0.01% | 708 |
|
|
2023
Q4 | $520K | Buy |
11,254
+1,504
| +15% | +$69.5K | 0.01% | 866 |
|
|
2023
Q3 | $397K | Buy |
9,750
+831
| +9% | +$33.8K | 0.01% | 908 |
|
|
2023
Q2 | $432K | Buy |
8,919
+1,802
| +25% | +$87.4K | 0.01% | 822 |
|
|
2023
Q1 | $351K | Buy |
7,117
+808
| +13% | +$39.8K | 0.01% | 814 |
|
|
2022
Q4 | $319K | Buy |
6,309
+75
| +1% | +$3.8K | 0.01% | 869 |
|
|
2022
Q3 | $313K | Buy |
6,234
+716
| +13% | +$35.9K | 0.01% | 843 |
|
|
2022
Q2 | $270K | Buy |
5,518
+1,962
| +55% | +$96K | 0.01% | 971 |
|
|
2022
Q1 | $214K | Buy |
+3,556
| New | +$214K | ﹤0.01% | 1137 |
|